Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Haemonetics Corporation (HAE)

-NYSE
33.60 Down 0.22(0.65%) Apr 23, 4:00PM EDT
|After Hours : 33.60 0.00 (0.00%) Apr 23, 4:28PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Haemonetics Corporation
400 Wood Road
Braintree, MA 02184
United States - Map
Phone: 781-848-7100
Website: http://www.haemonetics.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:3,563

Business Summary 

Haemonetics Corporation engages in the design, development, manufacture, and marketing of automated blood component collection devices and surgical blood salvage devices in the United States and internationally. It provides various plasma products, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and blood center products comprising multicomponent collection system brand apheresis equipment to collect specific blood components integrated from the donor, automated cell processor brand solution to automate the washing and freezing of red cell components in the lab, and filtration products. The company also offers various hospital products, such as TEG thrombelastograph hemostasis analyzer system that measures a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system for cardiovascular surgery procedures; OrthoPAT surgical blood salvage system for orthopedic procedures; cardioPAT system to open heart surgeries; and IMPACT Online Web-based software platform that monitors and measures improvements in a hospitalÂ’s blood management practices, provides hospitals with a view of their blood management metrics, and helps monitor transfusion rates. In addition, it offers SafeTrace Tx and BloodTrack suite of solutions, as well as El Dorado Donor donation and blood unit management systems. The company markets and sells its products to commercial plasma collectors, blood collection groups and independent blood centers, hospitals and hospital service providers, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Haemonetics Corporation

Corporate Governance 
Haemonetics Corporation’s ISS Governance QuickScore as of Apr 1, 2014 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Brian P. Concannon , 56
Chief Exec. Officer, Pres, Director and Member of Operating Committee
1.02M3.39M
Mr. Christopher J. Lindop , 56
Chief Financial Officer, Exec. VP of Bus. Devel. and Member of Operating Committee
678.00K1.56M
Mr. Peter M. Allen , 55
Pres of Global Plasma and Member of Operating Committee
673.00K2.96M
Mr. David D. Helsel , 50
Exec. VP of Global Manufacturing and Member of Operating Committee
586.00K0.00
Ms. Susan M. Hanlon , 46
Principal Accounting Officer, VP of Fin. and Member of Operating Committee
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders